353 related articles for article (PubMed ID: 20364084)
1. Glutaredoxin 5 deficiency causes sideroblastic anemia by specifically impairing heme biosynthesis and depleting cytosolic iron in human erythroblasts.
Ye H; Jeong SY; Ghosh MC; Kovtunovych G; Silvestri L; Ortillo D; Uchida N; Tisdale J; Camaschella C; Rouault TA
J Clin Invest; 2010 May; 120(5):1749-61. PubMed ID: 20364084
[TBL] [Abstract][Full Text] [Related]
2. The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload.
Camaschella C; Campanella A; De Falco L; Boschetto L; Merlini R; Silvestri L; Levi S; Iolascon A
Blood; 2007 Aug; 110(4):1353-8. PubMed ID: 17485548
[TBL] [Abstract][Full Text] [Related]
3. GLRX5 mutations impair heme biosynthetic enzymes ALA synthase 2 and ferrochelatase in Human congenital sideroblastic anemia.
Daher R; Mansouri A; Martelli A; Bayart S; Manceau H; Callebaut I; Moulouel B; Gouya L; Puy H; Kannengiesser C; Karim Z
Mol Genet Metab; 2019 Nov; 128(3):342-351. PubMed ID: 30660387
[TBL] [Abstract][Full Text] [Related]
4. [Recent progress in iron metabolism and iron-related anemia].
Harigae H
Rinsho Byori; 2010 Dec; 58(12):1211-8. PubMed ID: 21348241
[TBL] [Abstract][Full Text] [Related]
5. Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias.
Peoc'h K; Nicolas G; Schmitt C; Mirmiran A; Daher R; Lefebvre T; Gouya L; Karim Z; Puy H
Mol Genet Metab; 2019 Nov; 128(3):190-197. PubMed ID: 30737140
[TBL] [Abstract][Full Text] [Related]
6. Functional Analysis of GLRX5 Mutants Reveals Distinct Functionalities of GLRX5 Protein.
Liu G; Wang Y; Anderson GJ; Camaschella C; Chang Y; Nie G
J Cell Biochem; 2016 Jan; 117(1):207-17. PubMed ID: 26100117
[TBL] [Abstract][Full Text] [Related]
7. Hereditary sideroblastic anemias: pathophysiology, diagnosis, and treatment.
Camaschella C
Semin Hematol; 2009 Oct; 46(4):371-7. PubMed ID: 19786205
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis.
Wingert RA; Galloway JL; Barut B; Foott H; Fraenkel P; Axe JL; Weber GJ; Dooley K; Davidson AJ; Schmid B; Paw BH; Shaw GC; Kingsley P; Palis J; Schubert H; Chen O; Kaplan J; Zon LI;
Nature; 2005 Aug; 436(7053):1035-39. PubMed ID: 16110529
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathophysiology and genetic mutations in congenital sideroblastic anemia.
Fujiwara T; Harigae H
Free Radic Biol Med; 2019 Mar; 133():179-185. PubMed ID: 30098397
[TBL] [Abstract][Full Text] [Related]
10. Dimeric ferrochelatase bridges ABCB7 and ABCB10 homodimers in an architecturally defined molecular complex required for heme biosynthesis.
Maio N; Kim KS; Holmes-Hampton G; Singh A; Rouault TA
Haematologica; 2019 Sep; 104(9):1756-1767. PubMed ID: 30765471
[TBL] [Abstract][Full Text] [Related]
11. The molecular basis of the sideroblastic anemias.
Fitzsimons EJ; May A
Curr Opin Hematol; 1996 Mar; 3(2):167-72. PubMed ID: 9372069
[TBL] [Abstract][Full Text] [Related]
12. New mutation in erythroid-specific delta-aminolevulinate synthase as the cause of X-linked sideroblastic anemia responsive to pyridoxine.
Kucerova J; Horvathova M; Mojzikova R; Belohlavkova P; Cermak J; Divoky V
Acta Haematol; 2011; 125(4):193-7. PubMed ID: 21252495
[TBL] [Abstract][Full Text] [Related]
13. Aberrant iron accumulation and oxidized status of erythroid-specific delta-aminolevulinate synthase (ALAS2)-deficient definitive erythroblasts.
Harigae H; Nakajima O; Suwabe N; Yokoyama H; Furuyama K; Sasaki T; Kaku M; Yamamoto M; Sassa S
Blood; 2003 Feb; 101(3):1188-93. PubMed ID: 12393610
[TBL] [Abstract][Full Text] [Related]
14. Human iron-sulfur cluster assembly, cellular iron homeostasis, and disease.
Ye H; Rouault TA
Biochemistry; 2010 Jun; 49(24):4945-56. PubMed ID: 20481466
[TBL] [Abstract][Full Text] [Related]
15. Generation and Molecular Characterization of Human Ring Sideroblasts: a Key Role of Ferrous Iron in Terminal Erythroid Differentiation and Ring Sideroblast Formation.
Saito K; Fujiwara T; Hatta S; Morita M; Ono K; Suzuki C; Fukuhara N; Onishi Y; Nakamura Y; Kawamata S; Shimizu R; Yamamoto M; Harigae H
Mol Cell Biol; 2019 Apr; 39(7):. PubMed ID: 30670569
[TBL] [Abstract][Full Text] [Related]
16. Effect of 5-aminolevulinic acid on erythropoiesis: a preclinical in vitro characterization for the treatment of congenital sideroblastic anemia.
Fujiwara T; Okamoto K; Niikuni R; Takahashi K; Okitsu Y; Fukuhara N; Onishi Y; Ishizawa K; Ichinohasama R; Nakamura Y; Nakajima M; Tanaka T; Harigae H
Biochem Biophys Res Commun; 2014 Nov; 454(1):102-8. PubMed ID: 25450364
[TBL] [Abstract][Full Text] [Related]
17. Iron regulatory protein-1 protects against mitoferrin-1-deficient porphyria.
Chung J; Anderson SA; Gwynn B; Deck KM; Chen MJ; Langer NB; Shaw GC; Huston NC; Boyer LF; Datta S; Paradkar PN; Li L; Wei Z; Lambert AJ; Sahr K; Wittig JG; Chen W; Lu W; Galy B; Schlaeger TM; Hentze MW; Ward DM; Kaplan J; Eisenstein RS; Peters LL; Paw BH
J Biol Chem; 2014 Mar; 289(11):7835-43. PubMed ID: 24509859
[TBL] [Abstract][Full Text] [Related]
18. Congenital sideroblastic anemia model due to ALAS2 mutation is susceptible to ferroptosis.
Ono K; Fujiwara T; Saito K; Nishizawa H; Takahashi N; Suzuki C; Ochi T; Kato H; Ishii Y; Onodera K; Ichikawa S; Fukuhara N; Onishi Y; Yokoyama H; Yamada R; Nakamura Y; Igarashi K; Harigae H
Sci Rep; 2022 May; 12(1):9024. PubMed ID: 35637209
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology and genetic mutations in congenital sideroblastic anemia.
Fujiwara T; Harigae H
Pediatr Int; 2013 Dec; 55(6):675-9. PubMed ID: 24003969
[TBL] [Abstract][Full Text] [Related]
20. RNA silencing of the mitochondrial ABCB7 transporter in HeLa cells causes an iron-deficient phenotype with mitochondrial iron overload.
Cavadini P; Biasiotto G; Poli M; Levi S; Verardi R; Zanella I; Derosas M; Ingrassia R; Corrado M; Arosio P
Blood; 2007 Apr; 109(8):3552-9. PubMed ID: 17192393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
